Study to Assess PK, Safety and Tolerability in Healthy Subjects

Conditions: Acute Ischemic Stroke Interventions: Drug: QHRD106 Injection; Drug: Yurekline; Drug: placebo Sponsors: Changzhou Qianhong Bio-pharma Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials